University of Oklahoma

Bristol-myers Squibb Pharma Company

The Dupont Merck Pharmaceutical Company

Anurag S Srivastava

Kenneth M Nicholas

James David Rodgers

Soo Sung Ko

Hui-Yin Li

George A Boswell

Richard Gerald Wilde

Qiyan Lin

Barry L Johnson

Hollis S Kezar, Iii

Indawati DeLucca

Tricyclic compounds useful as HIV reverse transcriptase inhibitors

This invention provides amide compounds as inhibitors of acyl-Coenzyme A: cholesterol O-acyltransferase (ACAT), pharmaceutical compositions containing such compounds, processes for the preparation of such compounds, and the use of such compounds as antihypercholesterolemic and/or antiatherosclerotic agents.

Amides for the treatment of atherosclerosis

A process for making unsaturated .alpha.-amines from olefins wherein the process includes adding an aminating agent, an olefin and a molybdenum based catalyst to a reaction vessel having a nitrogen atmosphere. The catalyst may be described by the general formula LL'MoO.sub.2, L.sub.2 L'MoO.sub.2, or LL'MoO(X--Y).

Molybdenum-catalyzed amination of olefins

A process for making unsaturated .alpha.-amines from olefins wherein the process includes adding an aminating agent, an olefin and a molybdenum based catalyst to a reaction vessel having a nitrogen atmosphere. The catalyst may be described by the general formula LL'MoO.sub.2, L.sub.2 L'MoO.sub.2, or LL'MoO(X-Y).

Growing community of inventors

Newark, DE, United States of America

Anurag S Srivastava